Stock Analysis

Ami Organics First Quarter 2025 Earnings: EPS: ₹3.67 (vs ₹4.57 in 1Q 2024)

NSEI:AMIORG
Source: Shutterstock

Ami Organics (NSE:AMIORG) First Quarter 2025 Results

Key Financial Results

  • Revenue: ₹1.78b (up 25% from 1Q 2024).
  • Net income: ₹139.5m (down 16% from 1Q 2024).
  • Profit margin: 7.8% (down from 12% in 1Q 2024).
  • EPS: ₹3.67 (down from ₹4.57 in 1Q 2024).
earnings-and-revenue-growth
NSEI:AMIORG Earnings and Revenue Growth August 14th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Ami Organics Earnings Insights

Looking ahead, revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Pharmaceuticals industry in India.

Performance of the Indian Pharmaceuticals industry.

The company's shares are down 5.1% from a week ago.

Risk Analysis

Be aware that Ami Organics is showing 3 warning signs in our investment analysis that you should know about...

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NSEI:AMIORG

Ami Organics

Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.

Flawless balance sheet with high growth potential.